Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects

Eliana Disabella, Maurizia Grasso, Nicola Marziliano, Silvia Ansaldi, Claudia Lucchelli, Emanuele Porcu, Marilena Tagliani, Andrea Pilotto, Marta Diegoli, Luca Lanzarini, Clara Malattia, Antonio Pelliccia, Anna Ficcadenti, Orazio Gabrielli, Eloisa Arbustini

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

TGF-β-receptor 2 (TGFBR2) gene defects have been recently associated with Marfan syndrome (MFS) with prominent cardio-skeletal phenotype in patients with negative fibrillin-1 (FBN1) gene screening. Four mutations have been identified to date in five unrelated families. We screened TGFBR2 gene by direct automated sequencing in two adult patients diagnosed with MFS according to Ghent criteria, and in one girl clinically suspected as affected on the basis of a major cardiovascular criterion and skeletal involvement, all proven not to carry mutations in the exon -intron boundaries of FBN1 gene. We identified two novel and one known TGFBR2 gene mutations in the three unrelated probands. The D446N was identified in a 4-year-old girl with de novo disease characterized by severe cardiovascular disease and skeletal involvement. The M425V and R460H mutations were identified in two familial, autosomal dominant MFSs, both characterized by major cardio-skeletal signs and absence of major ocular signs. The mutation R460H has been recently reported in a family with thoracic aortic aneurysms and dissection. The three mutations are absent in 192 controls and affect evolutionarily conserved residues of the serine/threonine kinase domain (exon 5). Our data support the recently reported association between TGFBR2 gene and MFS without major ocular signs (MFS2). The number of genotyped cases however is too low to confirm that major ocular signs are characteristically absent in MFS2. Accordingly, all patients proven or suspected to be affected by MFS with negative FBN1 gene screening could benefit from rapid investigation of the TGFBR2 gene.

Original languageEnglish
Pages (from-to)34-38
Number of pages5
JournalEuropean Journal of Human Genetics
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Marfan Syndrome
Mutation
Genes
Exons
Thoracic Aortic Aneurysm
Fibrillin-1
Protein-Serine-Threonine Kinases
Introns
Dissection
Cardiovascular Diseases
Phenotype

Keywords

  • Fibrillin-1 gene (FBN1)
  • Marfan syndrome
  • TGF-β-receptor 2 (TGFBR2) gene

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. / Disabella, Eliana; Grasso, Maurizia; Marziliano, Nicola; Ansaldi, Silvia; Lucchelli, Claudia; Porcu, Emanuele; Tagliani, Marilena; Pilotto, Andrea; Diegoli, Marta; Lanzarini, Luca; Malattia, Clara; Pelliccia, Antonio; Ficcadenti, Anna; Gabrielli, Orazio; Arbustini, Eloisa.

In: European Journal of Human Genetics, Vol. 14, No. 1, 01.2006, p. 34-38.

Research output: Contribution to journalArticle

Disabella, Eliana ; Grasso, Maurizia ; Marziliano, Nicola ; Ansaldi, Silvia ; Lucchelli, Claudia ; Porcu, Emanuele ; Tagliani, Marilena ; Pilotto, Andrea ; Diegoli, Marta ; Lanzarini, Luca ; Malattia, Clara ; Pelliccia, Antonio ; Ficcadenti, Anna ; Gabrielli, Orazio ; Arbustini, Eloisa. / Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. In: European Journal of Human Genetics. 2006 ; Vol. 14, No. 1. pp. 34-38.
@article{936c8027303d4b8bbc40a9106b8a4f75,
title = "Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects",
abstract = "TGF-β-receptor 2 (TGFBR2) gene defects have been recently associated with Marfan syndrome (MFS) with prominent cardio-skeletal phenotype in patients with negative fibrillin-1 (FBN1) gene screening. Four mutations have been identified to date in five unrelated families. We screened TGFBR2 gene by direct automated sequencing in two adult patients diagnosed with MFS according to Ghent criteria, and in one girl clinically suspected as affected on the basis of a major cardiovascular criterion and skeletal involvement, all proven not to carry mutations in the exon -intron boundaries of FBN1 gene. We identified two novel and one known TGFBR2 gene mutations in the three unrelated probands. The D446N was identified in a 4-year-old girl with de novo disease characterized by severe cardiovascular disease and skeletal involvement. The M425V and R460H mutations were identified in two familial, autosomal dominant MFSs, both characterized by major cardio-skeletal signs and absence of major ocular signs. The mutation R460H has been recently reported in a family with thoracic aortic aneurysms and dissection. The three mutations are absent in 192 controls and affect evolutionarily conserved residues of the serine/threonine kinase domain (exon 5). Our data support the recently reported association between TGFBR2 gene and MFS without major ocular signs (MFS2). The number of genotyped cases however is too low to confirm that major ocular signs are characteristically absent in MFS2. Accordingly, all patients proven or suspected to be affected by MFS with negative FBN1 gene screening could benefit from rapid investigation of the TGFBR2 gene.",
keywords = "Fibrillin-1 gene (FBN1), Marfan syndrome, TGF-β-receptor 2 (TGFBR2) gene",
author = "Eliana Disabella and Maurizia Grasso and Nicola Marziliano and Silvia Ansaldi and Claudia Lucchelli and Emanuele Porcu and Marilena Tagliani and Andrea Pilotto and Marta Diegoli and Luca Lanzarini and Clara Malattia and Antonio Pelliccia and Anna Ficcadenti and Orazio Gabrielli and Eloisa Arbustini",
year = "2006",
month = "1",
doi = "10.1038/sj.ejhg.5201502",
language = "English",
volume = "14",
pages = "34--38",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects

AU - Disabella, Eliana

AU - Grasso, Maurizia

AU - Marziliano, Nicola

AU - Ansaldi, Silvia

AU - Lucchelli, Claudia

AU - Porcu, Emanuele

AU - Tagliani, Marilena

AU - Pilotto, Andrea

AU - Diegoli, Marta

AU - Lanzarini, Luca

AU - Malattia, Clara

AU - Pelliccia, Antonio

AU - Ficcadenti, Anna

AU - Gabrielli, Orazio

AU - Arbustini, Eloisa

PY - 2006/1

Y1 - 2006/1

N2 - TGF-β-receptor 2 (TGFBR2) gene defects have been recently associated with Marfan syndrome (MFS) with prominent cardio-skeletal phenotype in patients with negative fibrillin-1 (FBN1) gene screening. Four mutations have been identified to date in five unrelated families. We screened TGFBR2 gene by direct automated sequencing in two adult patients diagnosed with MFS according to Ghent criteria, and in one girl clinically suspected as affected on the basis of a major cardiovascular criterion and skeletal involvement, all proven not to carry mutations in the exon -intron boundaries of FBN1 gene. We identified two novel and one known TGFBR2 gene mutations in the three unrelated probands. The D446N was identified in a 4-year-old girl with de novo disease characterized by severe cardiovascular disease and skeletal involvement. The M425V and R460H mutations were identified in two familial, autosomal dominant MFSs, both characterized by major cardio-skeletal signs and absence of major ocular signs. The mutation R460H has been recently reported in a family with thoracic aortic aneurysms and dissection. The three mutations are absent in 192 controls and affect evolutionarily conserved residues of the serine/threonine kinase domain (exon 5). Our data support the recently reported association between TGFBR2 gene and MFS without major ocular signs (MFS2). The number of genotyped cases however is too low to confirm that major ocular signs are characteristically absent in MFS2. Accordingly, all patients proven or suspected to be affected by MFS with negative FBN1 gene screening could benefit from rapid investigation of the TGFBR2 gene.

AB - TGF-β-receptor 2 (TGFBR2) gene defects have been recently associated with Marfan syndrome (MFS) with prominent cardio-skeletal phenotype in patients with negative fibrillin-1 (FBN1) gene screening. Four mutations have been identified to date in five unrelated families. We screened TGFBR2 gene by direct automated sequencing in two adult patients diagnosed with MFS according to Ghent criteria, and in one girl clinically suspected as affected on the basis of a major cardiovascular criterion and skeletal involvement, all proven not to carry mutations in the exon -intron boundaries of FBN1 gene. We identified two novel and one known TGFBR2 gene mutations in the three unrelated probands. The D446N was identified in a 4-year-old girl with de novo disease characterized by severe cardiovascular disease and skeletal involvement. The M425V and R460H mutations were identified in two familial, autosomal dominant MFSs, both characterized by major cardio-skeletal signs and absence of major ocular signs. The mutation R460H has been recently reported in a family with thoracic aortic aneurysms and dissection. The three mutations are absent in 192 controls and affect evolutionarily conserved residues of the serine/threonine kinase domain (exon 5). Our data support the recently reported association between TGFBR2 gene and MFS without major ocular signs (MFS2). The number of genotyped cases however is too low to confirm that major ocular signs are characteristically absent in MFS2. Accordingly, all patients proven or suspected to be affected by MFS with negative FBN1 gene screening could benefit from rapid investigation of the TGFBR2 gene.

KW - Fibrillin-1 gene (FBN1)

KW - Marfan syndrome

KW - TGF-β-receptor 2 (TGFBR2) gene

UR - http://www.scopus.com/inward/record.url?scp=29644441249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29644441249&partnerID=8YFLogxK

U2 - 10.1038/sj.ejhg.5201502

DO - 10.1038/sj.ejhg.5201502

M3 - Article

C2 - 16251899

AN - SCOPUS:29644441249

VL - 14

SP - 34

EP - 38

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 1

ER -